4519.T-2.18%23.6%
ALNY-3.05%23.6%
ARWR+345.39%23.6%
WVE-20.63%23.6%
2257.HK-18.26%4.7%
NVO-31.16%1.0%
As of Jul 10, 2026, 7:14 AM ET
GLP-1 Long '26: RNA Fat Redistribution Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk A/SNVO | 100.0% | 0.93% | -0.02% | 1.12% | 0.23% | -3.93% | 30.52% | -28.37% | -31.16% | $217.21B |
Chugai Pharmaceutical Co., Ltd.4519.T | 23.6% | 0.00% | 0.19% | -2.84% | 1.07% | -13.51% | -31.81% | 1.89% | -2.18% | $75.09B |
Alnylam Pharmaceuticals, Inc.ALNY | 23.6% | 0.79% | -3.31% | 6.57% | 3.69% | -21.34% | -6.05% | 17.22% | -3.05% | $41.76B |
Arrowhead Pharmaceuticals, Inc.ARWR | 23.6% | 2.02% | -2.03% | 4.35% | 4.43% | 26.53% | 32.76% | 561.94% | 345.39% | $11.83B |
Wave Life Sciences Ltd.WVE | 23.6% | -0.16% | 1.12% | 11.09% | 8.05% | -62.88% | -54.70% | -16.64% | -20.63% | $1.21B |
Sirnaomics Ltd.2257.HK | 4.7% | 0.00% | 0.00% | -5.70% | -0.79% | -40.83% | -34.44% | 31.54% | -18.26% | $63.5M |
| Theme return | — | 0.63% | -0.95% | 4.26% | 4.73% | -18.84% | -15.78% | 72.13% | 37.96% | — |
| Average | 16.7% | 0.60% | -0.67% | 2.43% | 2.78% | -19.33% | -10.62% | 94.60% | 45.02% | $57.86B |
| Median | 23.6% | 0.40% | -0.01% | 2.74% | 2.38% | -17.42% | -18.93% | 9.56% | -10.65% | $26.80B |
| Std Dev | 9.8% | 0.76% | 1.51% | 5.65% | 2.99% | 28.10% | 33.05% | 209.95% | 134.71% | $75.96B |
| Min | 100.0% | -0.16% | -3.31% | -5.70% | -0.79% | -62.88% | -54.70% | -28.37% | -31.16% | $63.5M |
| Max | 23.6% | 2.02% | 1.12% | 11.09% | 8.05% | 26.53% | 32.76% | 561.94% | 345.39% | $217.21B |
| % Positive Tickers | 50.00% | 33.33% | 66.67% | 83.33% | 16.67% | 33.33% | 66.67% | 16.67% |
About this theme
GLP-1 Long '26: RNA Fat Redistribution tracks 6 publicly listed stocks in this theme: 2257.HK, 4519.T, ALNY, ARWR, NVO, WVE. See the constituent table for details.